Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6884
Source ID: NCT00619697
Associated Drug: Biphasic Insulin Aspart
Title: Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
Acronym: EUROMIX
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart|DRUG: insulin glargine|DRUG: metformin|DRUG: glimepiride
Outcome Measures: Primary: HbA1c, after 26 weeks of treatment | Secondary: HbA1c, after 16 weeks of treatment|Plasma glucose profiles|Change in body mass index|Incidence of hypoglycaemic episodes|Safety profile
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 260
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2003-12
Completion Date: 2005-03
Results First Posted:
Last Update Posted: 2017-01-06
Locations: Novo Nordisk Investigational Site, Ebreichsdorf, 2483, Austria|Novo Nordisk Investigational Site, Feldkirch, 6807, Austria|Novo Nordisk Investigational Site, Graz, 8036, Austria|Novo Nordisk Investigational Site, Horn, A 3580, Austria|Novo Nordisk Investigational Site, Oberpullendorf, 7350, Austria|Novo Nordisk Investigational Site, Salzburg, 5010, Austria|Novo Nordisk Investigational Site, Villach, A 9500, Austria|Novo Nordisk Investigational Site, Waidhofen a.d. Thaya, A 3830, Austria|Novo Nordisk Investigational Site, Brno, 65691, Czech Republic|Novo Nordisk Investigational Site, Liberec, 46001, Czech Republic|Novo Nordisk Investigational Site, Augsburg, 86150, Germany|Novo Nordisk Investigational Site, Castrop-Rauxel, 44577, Germany|Novo Nordisk Investigational Site, Deggingen, 73326, Germany|Novo Nordisk Investigational Site, Duisburg, 47053, Germany|Novo Nordisk Investigational Site, Erlangen, 91054, Germany|Novo Nordisk Investigational Site, Eschweiler, 52249, Germany|Novo Nordisk Investigational Site, Friedrichsthal, 66299, Germany|Novo Nordisk Investigational Site, Fulda, 36037, Germany|Novo Nordisk Investigational Site, Hamburg, 22119, Germany|Novo Nordisk Investigational Site, Hamburg, 22177, Germany|Novo Nordisk Investigational Site, Herne, 44623, Germany|Novo Nordisk Investigational Site, Kippenheim, 77971, Germany|Novo Nordisk Investigational Site, Lauffen, 74348, Germany|Novo Nordisk Investigational Site, Leverkusen, 51377, Germany|Novo Nordisk Investigational Site, Ludwigsburg, 71634, Germany|Novo Nordisk Investigational Site, Ludwigshafen, 67059, Germany|Novo Nordisk Investigational Site, Ludwigshafen, 67063, Germany|Novo Nordisk Investigational Site, Mannheim, 68161, Germany|Novo Nordisk Investigational Site, Mannheim, 68199, Germany|Novo Nordisk Investigational Site, Marburg, 35037, Germany|Novo Nordisk Investigational Site, Marburg, 35043, Germany|Novo Nordisk Investigational Site, Mülheim, 45468, Germany|Novo Nordisk Investigational Site, Neunkirchen, 66539, Germany|Novo Nordisk Investigational Site, Ostercappeln, 49179, Germany|Novo Nordisk Investigational Site, Pritzwalk, 16928, Germany|Novo Nordisk Investigational Site, Rosenheim, 83022, Germany|Novo Nordisk Investigational Site, Viernheim, 68519, Germany|Novo Nordisk Investigational Site, Weil der Stadt, 71263, Germany|Novo Nordisk Investigational Site, Weiskirchen, 66709, Germany|Novo Nordisk Investigational Site, Witten, 58452, Germany|Novo Nordisk Investigational Site, Witten, 58456, Germany|Novo Nordisk Investigational Site, Budapest, 1041, Hungary|Novo Nordisk Investigational Site, Eger, 3300, Hungary|Novo Nordisk Investigational Site, Szekszárd, 7100, Hungary|Novo Nordisk Investigational Site, Czestochowa, 42-200, Poland|Novo Nordisk Investigational Site, Gdynia, 81-366, Poland|Novo Nordisk Investigational Site, Lublin, 20 011, Poland|Novo Nordisk Investigational Site, Otwock, 05-400, Poland|Novo Nordisk Investigational Site, Poznan, 61-696, Poland|Novo Nordisk Investigational Site, L'ubochna, 03491, Slovakia|Novo Nordisk Investigational Site, Martin, 036 59, Slovakia|Novo Nordisk Investigational Site, Celje, 3000, Slovenia|Novo Nordisk Investigational Site, Ljubljana, 1000, Slovenia|Novo Nordisk Investigational Site, Maribor, 2000, Slovenia
URL: https://clinicaltrials.gov/show/NCT00619697

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D089 Metformin small molecule DB00331 Details